(The H4-Index of APMIS is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
Electronic reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID‐19 in Denmark55
The human microbiome in disease and pathology47
Studies on viral pneumonia related to novel coronavirus SARS‐CoV‐2, SARS‐CoV, and MERS‐CoV: a literature review33
Could SARS‐CoV‐2 infection affect male fertility and sexuality?32
Pandemics: past, present, future25
The Swedish public health response to COVID‐1925
Current and novel diagnostics for orthopedic implant biofilm infections: a review18
Human skin microbiota in health and disease17
SARS‐CoV‐2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID‐19 vaccination17
Pathogen‐associated molecular patterns and extracellular Hsp70 interplay in NLRP3 inflammasome activation in monocytic and bronchial epithelial cellular models of COPD exacerbations16
Role of IL‐22 in homeostasis and diseases of the skin16
Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer16
Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein15
Evaluation of Pseudomonas aeruginosa pathogenesis and therapeutics in military‐relevant animal infection models15
USP7, negatively regulated by miR‐409‐5p, aggravates hypoxia‐induced cardiomyocyte injury15
The gut microbiota can orchestrate the signaling pathways in colorectal cancer15